NASDAQ: 2.29
TSX: 2.89
Summary of Theratechnologies HIV Drug Therapy Glasgow 2018 presentation:
http://www.aidsmap.com/Prolonged-HIV-suppression-is-possible-using-ibalizumab-analysis-of-highly-drug-resistant-patients-shows/page/3361289/